Indo Borax Promoter Group Sells 50.80% Stake to Zenrock Chemicals for ₹418 Crore
Indo Borax & Chemicals Limited promoters are selling 50.80% stake (1,63,00,230 shares) for approximately ₹418 crore at ₹256.30 per share. The buyers, Zenrock Chemicals and funds, will trigger an open offer for an additional 26%. Three new directors will be appointed, and two existing directors will resign.
A change in promoter ownership of over 50% signifies a complete change in control and management of the company, which will have a significant impact on its future strategy, operations, and governance.
The transaction involves a substantial stake sale at a premium, indicating potential value realization for existing shareholders and a new strategic direction for the company under new management, which is generally viewed positively.
Indo Borax & Chemicals Limited has announced a significant change in its ownership structure. The promoter and promoter group, including Mr. Sajal Sushilkumar Jain, Mrs. Sreelekha Sajal Jain, Mr. Saumya Sajal Jain, Mrs. Pranika Saumya Jain, Sajal Sushilkumar Jain HUF, and Mrs. Shubhra Jain Sivaradjou (collectively, the "Sellers"), have executed a Share Purchase Agreement (SPA) dated December 15, 2025. Under this SPA, the Sellers will sell an aggregate of 1,63,00,230 equity shares, representing approximately 50.80% of the company's total paid-up equity share capital, to Zenrock Chemicals Private Limited, India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund (collectively, the "Purchasers").
The transaction is valued at ₹256.30 per share, amounting to a total deal value of approximately ₹418 crore. Upon completion of the transaction, the Sellers will cease to be in control of the Company and will be de-classified from the promoter/promoter group. The Acquirer will appoint three nominee directors to the Board, and existing directors Mr. Sajal Jain and Mr. Govind Ramlal Parmar will resign.
As per SEBI regulations, the Purchasers will be required to make an open offer to the eligible public shareholders for the acquisition of an additional 26% of the expanded voting share capital of the Company. The SPA includes customary representations, warranties, and indemnities, along with non-compete and non-solicit obligations for the Sellers. The consummation of the transaction is subject to customary conditions precedents.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.